Zolbend Plus 5mg/200mg Tablet
By Zolbend Plus
Rx
1 Tablet in a Strip

Composition
Ivermectin(5mg) + Albendazole(200mg)

Manufacturer - Morepen Laboratories Ltd
409, Antriksh Bhawan, 22 Kasturba Gandhi Marg, New Delhi - 110 001

Expires on or after
October, 2025

liver
It is important to be cautious when using Zolbend Plus 5mg/200mg Tablet if you have liver disease. Patients with liver issues may require a dose adjustment when taking this medication to ensure safety and effectiveness. It is advised to consult your doctor before starting treatment with Zolbend Plus 5mg/200mg Tablet. Be vigilant for any signs of jaundice such as yellowing of the eyes and skin, itching, and clay-colored stools while using this medicine, and promptly inform your healthcare provider of any concerning symptoms.

kidney
Zolbend Plus 5mg/200mg Tablet is considered safe for use in patients with kidney disease. Available data indicates that dosage adjustment of this medication may not be required for these patients. It is advisable to seek advice from your doctor regarding its use.

alcohol
Caution is advised when consuming alcohol with Zolbend Plus 5mg/200mg Tablet due to potential increased drowsiness.

driving
Zolbend Plus 5mg/200mg Tablet may reduce alertness, impact vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
Zolbend Plus 5mg/200mg Tablet may not be safe during pregnancy as animal studies suggest potential harm to the developing baby. Your doctor will assess benefits versus risks before prescribing. Kindly seek advice from your doctor beforehand.

breastfeeding
Zolbend Plus 5mg/200mg Tablet is considered safe for breastfeeding based on limited human data indicating no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹43
Inclusive of all taxes
Content verified by

Dr. Upasana Bhatia
MBBS - General Medicine
Last update on 11-Feb-2025